Variant · Snv
ETV6 R399H
CI-VAR-00003850Explore in graph →CIViC 5202
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 12406085
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Acute Lymphoblastic Leukemia1 | ||||||||
| ETV6::ABL2 Fusion AND ETV6 R399H | (oncogenic) | Oncogenic | D | Supports Oncogenicity | 1 | submitted | EID12492The patient derived MT-ALL cell line was established from a mature T-ALL in first relapse. Uncultured blasts had an immunophenotype of mature CD3+ TCRa/b+ T lymphocytes with a functional T-cell rece… (full text at CIViC) PMID 12406085 · Griesinger et al., 2002 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available